Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 8.21
+0.01 (0.12%)
Apr 24, 2026, 3:24 PM CET
Genfit Market Cap
Genfit has a market cap or net worth of €408.32 million as of April 24, 2026. Its market cap has increased by 182.17% in one year.
Market Cap
408.32M
Enterprise Value
457.92M
Revenue
65.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
€8.21
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 408.32M, an increase of 179.54%. That is a compound annual growth rate of 5.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 440.69M | 68.09% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.39B |
| DBV Technologies | 988.59M |
| Inventiva | 934.68M |
| MedinCell | 868.88M |
| Valneva SE | 416.14M |
| Cellectis | 242.45M |
| Transgene | 207.33M |
| Sensorion | 197.40M |